Biosensors: FULL YEAR FY2011

• Total revenue US$156.6 million, up 35% over FY10

• DES sales up 59% over FY10

• Licensing revenue US$17.2 million, up 89% over FY10

• Product gross margins 75% for FY11, compared to 70% in FY10
• JV non-operating contribution of US$19.3 million; up 29% over FY10

• Net profits of US$43.3 million, up 35% over FY10

• Positive cash flows from operations of US$27.8 million